269 related articles for article (PubMed ID: 33865797)
21. The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer.
Doan P; Katelaris A; Scheltema MJ; Hayen A; Amin A; Siriwardana A; Tran M; Geboers B; Gondoputro W; Haynes AM; Matthews J; Delprado W; Stricker PD; Thompson J
BMC Urol; 2023 Apr; 23(1):68. PubMed ID: 37118731
[TBL] [Abstract][Full Text] [Related]
22. Effect of pelvic lymph node dissection and its extent on oncological outcomes in intermediate-risk prostate cancer patients: A multicenter study of the Turkish Uro-oncology Association.
Izol V; Ok F; Aslan G; Akdogan B; Sozen S; Ozden E; Celik O; Muezzinoglu T; Turkeri L; Akdogan N; Baltaci S
Prostate; 2022 May; 82(7):763-771. PubMed ID: 35188993
[TBL] [Abstract][Full Text] [Related]
23. Indications for and anatomical extent of pelvic lymph node dissection for prostate cancer: practice patterns of uro-oncologists in North America.
Touijer KA; Ahallal Y; Guillonneau BD
Urol Oncol; 2013 Nov; 31(8):1517-21.e1-2. PubMed ID: 22687569
[TBL] [Abstract][Full Text] [Related]
24. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
[TBL] [Abstract][Full Text] [Related]
25. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
[TBL] [Abstract][Full Text] [Related]
26. Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.
Lattouf JB; Beri A; Jeschke S; Sega W; Leeb K; Janetschek G
Eur Urol; 2007 Nov; 52(5):1347-55. PubMed ID: 17507150
[TBL] [Abstract][Full Text] [Related]
27. Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature.
Ploussard G; Briganti A; de la Taille A; Haese A; Heidenreich A; Menon M; Sulser T; Tewari AK; Eastham JA
Eur Urol; 2014 Jan; 65(1):7-16. PubMed ID: 23582879
[TBL] [Abstract][Full Text] [Related]
28. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
[TBL] [Abstract][Full Text] [Related]
29. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer.
Clark T; Parekh DJ; Cookson MS; Chang SS; Smith ER; Wells N; Smith J
J Urol; 2003 Jan; 169(1):145-7; discussion 147-8. PubMed ID: 12478123
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic and therapeutic value of pelvic lymph node dissection in the fossa of Marcille in patients with clinically localized high-risk prostate cancer: Histopathological and molecular analyses.
Bando Y; Hinata N; Terakawa T; Furukawa J; Harada K; Nakano Y; Fujisawa M
Prostate; 2020 Mar; 80(4):345-351. PubMed ID: 31899555
[TBL] [Abstract][Full Text] [Related]
31. Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer.
Moschini M; Afferi L; Gandaglia G; D'Andrea D; Zamboni S; Di Bona C; Mordasini L; Mattei A; Baumeister P; Martini A; Burgio G; Shariat SF; Sanchez-Salas R; Cathelineau X; Stabile A; Zaffuto E; Salonia A; Colombo R; Necchi A; Montorsi F; Briganti A; Gallina A
Eur Urol Focus; 2021 Sep; 7(5):1067-1074. PubMed ID: 33020030
[TBL] [Abstract][Full Text] [Related]
32. Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer.
Fujimoto N; Shiota M; Tomisaki I; Minato A; Yahara K
Urol Int; 2019; 103(2):125-136. PubMed ID: 31039571
[TBL] [Abstract][Full Text] [Related]
33. The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period.
Gandaglia G; Trinh QD; Hu JC; Schiffmann J; Becker A; Roghmann F; Popa I; Tian Z; Perrotte P; Montorsi F; Briganti A; Karakiewicz PI; Sun M; Abdollah F
Eur J Surg Oncol; 2014 Sep; 40(9):1080-6. PubMed ID: 24411705
[TBL] [Abstract][Full Text] [Related]
34. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
[TBL] [Abstract][Full Text] [Related]
35. Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis.
Cacciamani GE; Maas M; Nassiri N; Ortega D; Gill K; Dell'Oglio P; Thalmann GN; Heidenreich A; Eastham JA; Evans CP; Karnes RJ; De Castro Abreu AL; Briganti A; Artibani W; Gill I; Montorsi F
Eur Urol Oncol; 2021 Apr; 4(2):134-149. PubMed ID: 33745687
[TBL] [Abstract][Full Text] [Related]
36. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database.
Chen J; Wang Z; Zhao J; Zhu S; Sun G; Liu J; Zhang H; Zhang X; Shen P; Shi M; Zeng H
Sci Rep; 2019 Nov; 9(1):17985. PubMed ID: 31784574
[TBL] [Abstract][Full Text] [Related]
37. Does pelvic lymph node dissection improve the biochemical relapse-free survival in low-risk prostate cancer patients treated by laparoscopic radical prostatectomy?
Daimon T; Miyajima A; Maeda T; Hattori S; Yasumizu Y; Hasegawa M; Kosaka T; Kikuchi E; Nakagawa K; Oya M
J Endourol; 2012 Sep; 26(9):1199-202. PubMed ID: 22524402
[TBL] [Abstract][Full Text] [Related]
38. Oncological Outcome After Radical Prostatectomy without Pelvic Lymph Node Dissection for Localized Prostate Cancer: Follow-up Results in a Single Institution.
Tomisaki I; Ikuta H; Higashijima K; Onishi R; Minato A; Fujimoto N
Cancer Invest; 2019; 37(10):524-530. PubMed ID: 31597501
[TBL] [Abstract][Full Text] [Related]
39. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
[TBL] [Abstract][Full Text] [Related]
40. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]